240 related articles for article (PubMed ID: 35838808)
1. Retinal and choroidal vasoreactivity in central serous chorioretinopathy.
Penas S; Araújo T; Mendonça AM; Faria S; Silva J; Campilho A; Martins ML; Sousa V; Rocha-Sousa A; Carneiro Â; Falcão-Reis F
Graefes Arch Clin Exp Ophthalmol; 2022 Dec; 260(12):3825-3836. PubMed ID: 35838808
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of choroidal hyperreflective dots in acute and chronic central serous chorioretinopathy.
Hanumunthadu D; Matet A; Rasheed MA; Goud A; Vuppurabina KK; Chhablani J
Indian J Ophthalmol; 2019 Nov; 67(11):1850-1854. PubMed ID: 31638047
[TBL] [Abstract][Full Text] [Related]
3. Choroidal thickness measurement by enhanced depth imaging and swept-source optical coherence tomography in central serous chorioretinopathy.
Hamzah F; Shinojima A; Mori R; Yuzawa M
BMC Ophthalmol; 2014 Nov; 14():145. PubMed ID: 25421855
[TBL] [Abstract][Full Text] [Related]
4. Choroidal vessel diameter in central serous chorioretinopathy.
Yang L; Jonas JB; Wei W
Acta Ophthalmol; 2013 Aug; 91(5):e358-62. PubMed ID: 23647989
[TBL] [Abstract][Full Text] [Related]
5. Morphologic features of large choroidal vessel layer: age-related macular degeneration, polypoidal choroidal vasculopathy, and central serous chorioretinopathy.
Baek J; Lee JH; Jung BJ; Kook L; Lee WK
Graefes Arch Clin Exp Ophthalmol; 2018 Dec; 256(12):2309-2317. PubMed ID: 30259090
[TBL] [Abstract][Full Text] [Related]
6. SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR DIAMETER IN ACTIVE AND RESOLVED CENTRAL SEROUS CHORIORETINOPATHY.
Chung YR; Kim JW; Choi SY; Park SW; Kim JH; Lee K
Retina; 2018 Jan; 38(1):102-107. PubMed ID: 28106708
[TBL] [Abstract][Full Text] [Related]
7. Clinical evaluation of neovascular and non-neovascular chronic central serous chorioretinopathy (CSC) diagnosed by swept source optical coherence tomography angiography (SS OCTA).
Sulzbacher F; Schütze C; Burgmüller M; Vécsei-Marlovits PV; Weingessel B
Graefes Arch Clin Exp Ophthalmol; 2019 Aug; 257(8):1581-1590. PubMed ID: 31037488
[TBL] [Abstract][Full Text] [Related]
8. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients.
Ersoz MG; Arf S; Hocaoglu M; Sayman Muslubas I; Karacorlu M
Br J Ophthalmol; 2019 Jun; 103(6):725-729. PubMed ID: 30002072
[TBL] [Abstract][Full Text] [Related]
9. Assessment of macular choroidal thickness by optical coherence tomography and angiographic changes in central serous chorioretinopathy.
Jirarattanasopa P; Ooto S; Tsujikawa A; Yamashiro K; Hangai M; Hirata M; Matsumoto A; Yoshimura N
Ophthalmology; 2012 Aug; 119(8):1666-78. PubMed ID: 22521082
[TBL] [Abstract][Full Text] [Related]
10. Choriocapillaris flow features and choroidal vasculature in the fellow eyes of patients with acute central serous chorioretinopathy.
Yun C; Huh J; Ahn SM; Lee B; Kim JT; Hwang SY; Kim SW; Oh J
Graefes Arch Clin Exp Ophthalmol; 2019 Jan; 257(1):57-70. PubMed ID: 30397792
[TBL] [Abstract][Full Text] [Related]
11. Multimodal Imaging in Fibrinous Central Serous Chorioretinopathy Compared with Exudative Maculopathy.
Lyu Y; Li X; Gong Y
Ophthalmologica; 2020; 243(5):360-369. PubMed ID: 32008002
[TBL] [Abstract][Full Text] [Related]
12. Three-dimensional choroidal vascularity index in acute central serous chorioretinopathy using swept-source optical coherence tomography.
Yang J; Wang E; Yuan M; Chen Y
Graefes Arch Clin Exp Ophthalmol; 2020 Feb; 258(2):241-247. PubMed ID: 31724090
[TBL] [Abstract][Full Text] [Related]
13. Subfoveal choroidal thickness after treatment of central serous chorioretinopathy.
Maruko I; Iida T; Sugano Y; Ojima A; Ogasawara M; Spaide RF
Ophthalmology; 2010 Sep; 117(9):1792-9. PubMed ID: 20472289
[TBL] [Abstract][Full Text] [Related]
14. Optical coherent tomographic angiographic pattern of the deep choroidal layer and choriocapillaris after photodynamic therapy for central serous chorioretinopathy.
Chan SY; Pan CT; Wang Q; Shi XH; Jonas JB; Wei WB
Graefes Arch Clin Exp Ophthalmol; 2019 Jul; 257(7):1365-1372. PubMed ID: 31037490
[TBL] [Abstract][Full Text] [Related]
15. Biometric characteristics of eyes with central serous chorioretinopathy.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Invest Ophthalmol Vis Sci; 2014 Mar; 55(3):1502-8. PubMed ID: 24550360
[TBL] [Abstract][Full Text] [Related]
16. Choroidal thickness in central serous chorioretinopathy.
Kuroda S; Ikuno Y; Yasuno Y; Nakai K; Usui S; Sawa M; Tsujikawa M; Gomi F; Nishida K
Retina; 2013 Feb; 33(2):302-8. PubMed ID: 23064424
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of fundus fluorescein angiography, indocyanine green angiography and choroidal thickness in central serous chorioretinopathy].
Li L; Li DH; Yang ZK; Bian AL; Chen YX; Dong FT
Zhonghua Yan Ke Za Zhi; 2012 Oct; 48(10):878-82. PubMed ID: 23302240
[TBL] [Abstract][Full Text] [Related]
18. Choroidal Vascular Flow Area in Central Serous Chorioretinopathy Using Swept-Source Optical Coherence Tomography Angiography.
Nicolò M; Rosa R; Musetti D; Musolino M; Saccheggiani M; Traverso CE
Invest Ophthalmol Vis Sci; 2017 Apr; 58(4):2002-2010. PubMed ID: 28384721
[TBL] [Abstract][Full Text] [Related]
19. CHOROIDAL THICKNESS OF CENTRAL SEROUS CHORIORETINOPATHY SECONDARY TO CORTICOSTEROID USE.
Honda S; Miki A; Kusuhara S; Imai H; Nakamura M
Retina; 2017 Aug; 37(8):1562-1567. PubMed ID: 27787451
[TBL] [Abstract][Full Text] [Related]
20. Quantitative assessment of choroidal parameters and retinal thickness in central serous chorioretinopathy using ultra-widefield swept-source optical coherence tomography: a cross-sectional study.
Xiao B; Yan M; Song YP; Ye Y; Huang Z
BMC Ophthalmol; 2024 Apr; 24(1):176. PubMed ID: 38632531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
